Search Contract Opportunities

Budesonide Inhalation Suspension   2

ID: Solicitation_SPE2D224R0005 • Type: Solicitation

Description

Posted: Dec. 18, 2024, 7:39 a.m. EST

Amendment 0007 to cancel the solicitation is attached.

Posted: April 24, 2024, 2:07 p.m. EDT
Posted: April 24, 2024, 1:54 p.m. EDT
Posted: April 23, 2024, 2:44 p.m. EDT
Posted: April 23, 2024, 1:00 p.m. EDT
Posted: April 22, 2024, 2:41 p.m. EDT
Posted: April 19, 2024, 1:56 p.m. EDT
Posted: April 10, 2024, 3:33 p.m. EDT
Posted: March 13, 2024, 8:57 a.m. EDT
Posted: March 12, 2024, 9:05 a.m. EDT
Background
The Defense Logistics Agency (DLA) Troop Support, Directorate of Medical Materiel provides pharmaceutical products for the Department of Defense (DoD) to its customers through its Pharmaceutical Prime Vendor program. The Department of Veterans Affairs (VA) provides pharmaceutical products to its customers as well as the Indian Health Service (IHS) and the Bureau of Prisons (BoP) through the VA Pharmaceutical Prime Vendor Program. Hereafter these programs are collectively referred to as the “PPV.” A prime vendor is an independent business concern that functions as a purchaser's primary source for specified classes of products and is responsible for the delivery of goods produced by various suppliers.
As a part of the Pharmaceutical Prime Vendor Program, this solicitation will establish a national contract for the items listed in the schedule. The PPV Programs consist of separate contracts which establish the fees for the distribution of pharmaceutical products that are distributed through the PPV Programs on Federal Government (i.e., Federal Supply Schedules, DLA National Contracts) contracts. The awardee consents to allow VA and DLA Troop Support Prime Vendors to distribute the listed products in the schedule.

Work Details
Budesonide Inhalation Suspension 0.25MG/2ML* - Base Year: 20,297; Option Year 1: 20,297; Option Year 2: 20,297; Option Year 3: 20,297; Option Year 4: 20,297.
Budesonide Inhalation Suspension 0.5MG/2ML* - Base Year: 175,665; Option Year 1: 175,665; Option Year 2: 175,665; Option Year 3: 175,665; Option Year 4: 175,665. *BT - Package size is unit of use and is subject to Statement of Work – “Preparation for Delivery” requirement.

Period of Performance
The Contract Price Effective Date shall be no more than 60 calendar days after award, but no sooner than July 1, 2024. The contract performance date shall be 45 calendar days (or sooner upon mutual agreement) after the date of contract award.

Place of Performance
The complete order quantity shall be delivered to the PPV contractors within 15 calendar days after receipt of order.

Overview

Response Deadline
May 2, 2024, 3:00 p.m. EDT (original: April 11, 2024, 3:00 p.m. EDT) Past Due
Posted
March 12, 2024, 9:05 a.m. EDT (updated: Dec. 18, 2024, 7:39 a.m. EST)
Set Aside
None
Place of Performance
Not Provided
Source
SAM

Current SBA Size Standard
1300 Employees
Pricing
Likely Fixed Price
Est. Level of Competition
Average
Est. Value Range
Experimental
$1,000,000 - $5,000,000 (AI estimate)
On 3/12/24 DLA Troop Support - Medical issued Solicitation Solicitation_SPE2D224R0005 for Budesonide Inhalation Suspension due 5/2/24. The opportunity was issued full & open with NAICS 325412 and PSC 6505.
Primary Contact
Name
Nancy Fernandez   Profile
Phone
(215) 737-4955

Secondary Contact

Name
Catherine Gilbert   Profile
Phone
(215) 737-4778

Documents

Posted documents for Solicitation Solicitation_SPE2D224R0005

Question & Answer

Opportunity Lifecycle

Procurement notices related to Solicitation Solicitation_SPE2D224R0005

Incumbent or Similar Awards

Potential Bidders and Partners

Awardees that have won contracts similar to Solicitation Solicitation_SPE2D224R0005

Similar Active Opportunities

Open contract opportunities similar to Solicitation Solicitation_SPE2D224R0005

Additional Details

Source Agency Hierarchy
DEPT OF DEFENSE > DEFENSE LOGISTICS AGENCY (DLA) > TROOP SUPPORT MEDICAL > DLA TROOP SUPPORT
FPDS Organization Code
97AS-SPE2D2
Source Organization Code
500045947
Last Updated
Dec. 18, 2024
Last Updated By
nancy.fernandez@dla.mil
Archive Date
April 25, 2029